Alcon Pharms Ltd patents expiration
1. Betaxon patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5540918 | ALCON PHARMS LTD | Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
Jul, 2013
(10 years ago) | |
|
US5540918 (Pediatric) | ALCON PHARMS LTD | Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
Jan, 2014
(10 years ago) | |
Drugs and Companies using LEVOBETAXOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 23 February, 2000
Treatment: NA
Dosage: SUSPENSION/DROPS;OPHTHALMIC
More Information on Dosage
BETAXON family patents
2. Navstel patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7084130 | ALCON PHARMS LTD | Intraocular irrigating solution having improved flow characteristics |
Nov, 2021
(2 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Jul 24, 2011 |
Market Authorisation Date: 24 July, 2008
Treatment: Use as an intraocular irrigating solution during surgical procedures involving perfusion of the eye
Dosage: SOLUTION;IRRIGATION
More Information on Dosage
NAVSTEL family patents
3. Travatan patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5510383 | ALCON PHARMS LTD | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
Aug, 2013
(10 years ago) | |
| US5889052 | ALCON PHARMS LTD | Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension |
Dec, 2014
(9 years ago) | |
| US5849792 | ALCON PHARMS LTD | Storage-stable prostaglandin compositions |
Dec, 2014
(9 years ago) | |
| US6011062 | ALCON PHARMS LTD | Storage-stable prostaglandin compositions |
Dec, 2014
(9 years ago) | |
| US5631287 | ALCON PHARMS LTD | Storage-stable prostaglandin compositions |
Dec, 2014
(9 years ago) | |
Drugs and Companies using TRAVOPROST ingredient
Market Authorisation Date: 16 March, 2001
Treatment: Method for treating glaucoma and ocular hypertension; Method of stabilizing prostaglandin
Dosage: SOLUTION/DROPS;OPHTHALMIC
How can I launch a generic of TRAVATAN before it's drug patent expiration?
More Information on Dosage
TRAVATAN family patents